Heestermans, R.; De Brouwer, W.; Maes, K.; Vande Broek, I.; Vaeyens, F.; Olsen, C.; Caljon, B.; De Becker, A.; Bakkus, M.; Schots, R.;
et al. Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study. Cancers 2022, 14, 4901.
https://doi.org/10.3390/cancers14194901
AMA Style
Heestermans R, De Brouwer W, Maes K, Vande Broek I, Vaeyens F, Olsen C, Caljon B, De Becker A, Bakkus M, Schots R,
et al. Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study. Cancers. 2022; 14(19):4901.
https://doi.org/10.3390/cancers14194901
Chicago/Turabian Style
Heestermans, Robbe, Wouter De Brouwer, Ken Maes, Isabelle Vande Broek, Freya Vaeyens, Catharina Olsen, Ben Caljon, Ann De Becker, Marleen Bakkus, Rik Schots,
and et al. 2022. "Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study" Cancers 14, no. 19: 4901.
https://doi.org/10.3390/cancers14194901
APA Style
Heestermans, R., De Brouwer, W., Maes, K., Vande Broek, I., Vaeyens, F., Olsen, C., Caljon, B., De Becker, A., Bakkus, M., Schots, R., & Van Riet, I.
(2022). Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study. Cancers, 14(19), 4901.
https://doi.org/10.3390/cancers14194901